Skip to content

Antibiogram and Biofilm Formation of Bacteria Causing Prosthetic Joint Infections Isolated From Assiut University Hospital

Antibiogram and Biofilm Formation of Bacteria Causing Prosthetic Joint Infections Isolated From Assiut University Hospital

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05239312
Enrollment
90
Registered
2022-02-14
Start date
2022-03-31
Completion date
2024-05-31
Last updated
2022-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prosthetic Joint Infection

Brief summary

1. Setting of antibiogram in orthopedic department 2. Evaluate the production of biofilm in bacteria isolated from specimens phenotypically and genotypically.

Detailed description

Increased use of total joint arthroplasties will naturally result in a related increase in the number of prosthetic joint infections (PJIs). PJI is a disastrous complication of orthopedic surgery, frequently leading to prolonged morbidity and increased mortality. Moreover, therapy for PJI is associated with enormous costs. PJI results from numerous factors that lead to inability of periprosthetic immune cells to protect implant surfaces and tissues from bacterial colonization. The most destabilizing factor is the ability of bacteria to adhere to and survive on virtually all natural and synthetic surfaces. Once firmly attached to the surface of an implant, the microorganisms initiate biofilm formation, which is a complex of microbial cells embedded in an extracellular matrix composed of proteins, extracellular DNA, and exopolysaccharides, providing protection for bacteria and making them extremely resistant to the immune system and antibiotic. An ineffective empiric antibiotic regimen can be harmful to patients while unnecessary broad-spectrum antibiotics lead to increased resistance. However, healthcare providers often select an antibiotic regimen before bacterial antibiotic sensitivities are available. The Clinical and Laboratory of Standards Institute publishes the M39 Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data; Approved Guideline, which is a referenced guideline on how to create antibiograms. The antibiogram has multiple uses, including providing guidance for empiric antibiotic therapy, monitoring changes in resistance over time, assisting in formulary decisions and supports antimicrobial stewardship programs to reduce multidrug resistant organisms and the risks of adverse drug events.

Interventions

Implementation of antimicrobial protocol for empirical treatment which will be done according to the results of antibiotic susceptibility

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Inclusion criteria: * Age above 18 years old * no intraarticular surgery of the respective joint prior to the index surgery. 2.

Exclusion criteria

* Age below 18 years old * If the patient had any intraarticular surgery prior to the primary arthroplasty in the respective joint.

Design outcomes

Primary

MeasureTime frameDescription
Antibiogram for PJI18 monthsPercentages of different bacterial species causing prosthetic joint infection and their Antimicrobial sensitivity pattern.

Secondary

MeasureTime frameDescription
Biofilm formation18 monthsPercentage of different bacteria responsible for biofilm formation

Contacts

Primary ContactAmina Abd El Aal Mohammed
amina.makhlouf.26@gmail.com01006956223
Backup ContactHebat Allah G. Rashed
hebager@yahoo.com01003997231

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026